524606 BERLDRG

Beryl Drugs Share Price

 

 

Start SIP in BERLDRG

Start SIP

Performance

  • Low
  • ₹21
  • High
  • ₹22
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹35
  • Open Price₹22
  • Previous Close₹22
  • Volume15,815
  • 50 DMA₹22.42
  • 100 DMA₹22.61
  • 200 DMA₹23.48

Investment Returns

  • Over 1 Month -4.66%
  • Over 3 Month -9.59%
  • Over 6 Month + 12.04%
  • Over 1 Year -34.62%

Smart Investing Starts Here Start SIP with Beryl Drugs for Steady Growth!

Invest Now

Beryl Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 774.3
  • PEG Ratio
  • -9.4
  • Market Cap Cr
  • 11
  • P/B Ratio
  • 1.2
  • Average True Range
  • 1.12
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.19
  • RSI
  • 45.75
  • MFI
  • 35.23

Beryl Drugs Financials

Beryl Drugs Technicals

EMA & SMA

Current Price
₹21.68
-0.32 (-1.45%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹22.11
  • 50 Day
  • ₹22.42
  • 100 Day
  • ₹22.61
  • 200 Day
  • ₹23.48

Resistance and Support

21.64 Pivot Speed
  • R3 23.54
  • R2 22.89
  • R1 22.29
  • S1 21.04
  • S2 20.39
  • S3 19.79

Beryl Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-09 Quarterly Results
2026-01-03 Others
2025-11-13 Quarterly Results
2025-09-02 A.G.M.
2025-08-07 Quarterly Results

Beryl Drugs F&O

Beryl Drugs Shareholding Pattern

26.38%
66.25%
7.37%

About Beryl Drugs

  • NSE Symbol
  • BERLDRG
  • BSE Symbol
  • 524606
  • Managing Director
  • Mr. Sanjay Sethi
  • ISIN
  • INE415H01017

Similar Stocks to Beryl Drugs

Beryl Drugs FAQs

Beryl Drugs share price is ₹21 As on 11 February, 2026 | 02:29

The Market Cap of Beryl Drugs is ₹11 Cr As on 11 February, 2026 | 02:29

The P/E ratio of Beryl Drugs is 774.3 As on 11 February, 2026 | 02:29

The PB ratio of Beryl Drugs is 1.2 As on 11 February, 2026 | 02:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23